BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 11544328)

  • 1. The effect of an anti-HLA-B27 immune response on CTL recognition of Chlamydia.
    Popov I; Dela Cruz CS; Barber BH; Chiu B; Inman RD
    J Immunol; 2001 Sep; 167(6):3375-82. PubMed ID: 11544328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breakdown of CTL tolerance to self HLA-B*2705 induced by exposure to Chlamydia trachomatis.
    Popov I; Dela Cruz CS; Barber BH; Chiu B; Inman RD
    J Immunol; 2002 Oct; 169(7):4033-8. PubMed ID: 12244206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recognition of chlamydial antigen by HLA-B27-restricted cytotoxic T cells in HLA-B*2705 transgenic CBA (H-2k) mice.
    Kuon W; Lauster R; Böttcher U; Koroknay A; Ulbrecht M; Hartmann M; Grolms M; Ugrinovic S; Braun J; Weiss EH; Sieper J
    Arthritis Rheum; 1997 May; 40(5):945-54. PubMed ID: 9153558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic T-cell-mediated response against Yersinia pseudotuberculosis in HLA-B27 transgenic rat.
    Falgarone G; Blanchard HS; Riot B; Simonet M; Breban M
    Infect Immun; 1999 Aug; 67(8):3773-9. PubMed ID: 10417137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization of HLA-B27 transgenic and non transgenic mice with Salmonella typhimurium results predominantly in the generation of proliferative T cell responses.
    Ringrose JH; Yard BA; Verjans GM; Boog CJ
    Clin Rheumatol; 1996 Jan; 15 Suppl 1():79-85. PubMed ID: 8835510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of HLA-B27 tetramers to identify low-frequency antigen-specific T cells in Chlamydia-triggered reactive arthritis.
    Appel H; Kuon W; Kuhne M; Wu P; Kuhlmann S; Kollnberger S; Thiel A; Bowness P; Sieper J
    Arthritis Res Ther; 2004; 6(6):R521-34. PubMed ID: 15535830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity and frequency of primary anti-HLA cytotoxic T lymphocytes in normal and HLA-B27.2-, HLA-B27.5-, and HLA-Cw3-transgenic mice. A transgenic model for MHC xenoantigen recognition.
    Kievits F; Boerenkamp WJ; Lokhorst W; Ivanyi P
    J Immunol; 1990 Jun; 144(12):4513-9. PubMed ID: 2351823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rat MHC-linked peptide transporter alleles strongly influence peptide binding by HLA-B27 but not B27-associated inflammatory disease.
    Simmons WA; Leong LY; Satumtira N; Butcher GW; Howard JC; Richardson JA; Slaughter CA; Hammer RE; Taurog JD
    J Immunol; 1996 Feb; 156(4):1661-7. PubMed ID: 8568273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-B27-restricted cytotoxic T lymphocyte responses to arthritogenic enterobacteria or self-antigens are dominated by closely related TCRBV gene segments. A study in patients with reactive arthritis.
    Duchmann R; May E; Ackermann B; Goergen B; Meyer zum Büschenfelde KH; Märker-Hermann E
    Scand J Immunol; 1996 Jan; 43(1):101-8. PubMed ID: 8560188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel HLA-B27-restricted epitopes from Chlamydia trachomatis generated upon endogenous processing of bacterial proteins suggest a role of molecular mimicry in reactive arthritis.
    Alvarez-Navarro C; Cragnolini JJ; Dos Santos HG; Barnea E; Admon A; Morreale A; López de Castro JA
    J Biol Chem; 2013 Sep; 288(36):25810-25825. PubMed ID: 23867464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of HLA-B27-restricted peptides from the Chlamydia trachomatis proteome with possible relevance to HLA-B27-associated diseases.
    Kuon W; Holzhütter HG; Appel H; Grolms M; Kollnberger S; Traeder A; Henklein P; Weiss E; Thiel A; Lauster R; Bowness P; Radbruch A; Kloetzel PM; Sieper J
    J Immunol; 2001 Oct; 167(8):4738-46. PubMed ID: 11591805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The specificity of peptides bound to human histocompatibility leukocyte antigen (HLA)-B27 influences the prevalence of arthritis in HLA-B27 transgenic rats.
    Zhou M; Sayad A; Simmons WA; Jones RC; Maika SD; Satumtira N; Dorris ML; Gaskell SJ; Bordoli RS; Sartor RB; Slaughter CA; Richardson JA; Hammer RE; Taurog JD
    J Exp Med; 1998 Sep; 188(5):877-86. PubMed ID: 9730889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective costimulatory function is a striking feature of antigen-presenting cells in an HLA-B27-transgenic rat model of spondylarthropathy.
    Hacquard-Bouder C; Falgarone G; Bosquet A; Smaoui F; Monnet D; Ittah M; Breban M
    Arthritis Rheum; 2004 May; 50(5):1624-35. PubMed ID: 15146433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous processing and presentation of T-cell epitopes from Chlamydia trachomatis with relevance in HLA-B27-associated reactive arthritis.
    Cragnolini JJ; García-Medel N; de Castro JA
    Mol Cell Proteomics; 2009 Aug; 8(8):1850-9. PubMed ID: 19443418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD8 alpha beta T cells are not essential to the pathogenesis of arthritis or colitis in HLA-B27 transgenic rats.
    May E; Dorris ML; Satumtira N; Iqbal I; Rehman MI; Lightfoot E; Taurog JD
    J Immunol; 2003 Jan; 170(2):1099-105. PubMed ID: 12517979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-B27 expression does not modulate intracellular Chlamydia trachomatis infection of cell lines.
    Young JL; Smith L; Matyszak MK; Gaston JS
    Infect Immun; 2001 Nov; 69(11):6670-5. PubMed ID: 11598036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-antigen presenting effects of HLA-B27.
    Penttinen MA; Ekman P; Granfors K
    Curr Mol Med; 2004 Feb; 4(1):41-9. PubMed ID: 15011958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sharing of an HLA-B27-restricted H-Y antigen between rat and mouse.
    Simmons WA; Taurog JD; Hammer RE; Breban M
    Immunogenetics; 1993; 38(5):351-8. PubMed ID: 8344721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-B27 misfolding in transgenic rats is associated with activation of the unfolded protein response.
    Turner MJ; Sowders DP; DeLay ML; Mohapatra R; Bai S; Smith JA; Brandewie JR; Taurog JD; Colbert RA
    J Immunol; 2005 Aug; 175(4):2438-48. PubMed ID: 16081815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xenogeneic and allogeneic anti-MHC immune responses induced by plasmid DNA immunization.
    Dela Cruz CS; Chamberlain JW; MacDonald KS; Barber BH
    Vaccine; 1999 Jun; 17(20-21):2479-92. PubMed ID: 10418893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.